Transfer hydrogenation process and catalyst

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6545188
APP PUB NO 20020156282A1
SERIAL NO

10083391

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A catalytic transfer hydrogenation process is provided. The catalyst employed in the process is a metal cyclopentadienyl complex which is coordinated to defined bidentate ligands. Preferred metals include rhodium, ruthenium and iridium. Preferred bidentate ligands are diamines and aminoalcohols, particularly those comprising chiral centers. The hydrogen donor is advantageously a secondary alcohol or a mixture of triethylamine and formic acid. The process can be employed to transfer hydrogenate ketones and imines, which are preferably prochiral. Catalysts for use in such a process are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AVECIA PHARMACEUTICALS LIMITEDBLACKLEY MANCHESTER M9 8ZS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Blacker, Andrew John Huddersfield, GB 19 162
Mellor, Ben James Grangemouth, GB 4 152

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation